KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Precigen (PGEN) Equity Income (2016 - 2025)

Precigen (PGEN) has disclosed Equity Income for 11 consecutive years, with -$111.5 million as the latest value for Q3 2025.

  • Quarterly Equity Income changed N/A to -$111.5 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$139.5 million through Dec 2025, changed N/A year-over-year, with the annual reading at -$139.5 million for FY2025, N/A changed from the prior year.
  • Equity Income for Q3 2025 was -$111.5 million at Precigen, down from $4.5 million in the prior quarter.
  • The five-year high for Equity Income was $4.5 million in Q2 2025, with the low at -$111.5 million in Q3 2025.
  • Average Equity Income over 3 years is -$19.8 million, with a median of -$1000.0 recorded in 2022.
  • The sharpest move saw Equity Income surged 99.23% in 2021, then surged 66.67% in 2022.
  • Over 3 years, Equity Income stood at -$3000.0 in 2021, then skyrocketed by 133.33% to $1000.0 in 2022, then plummeted by 11150300.0% to -$111.5 million in 2025.
  • According to Business Quant data, Equity Income over the past three periods came in at -$111.5 million, $4.5 million, and -$32.5 million for Q3 2025, Q2 2025, and Q1 2025 respectively.